RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AFT Pharmaceuticals Stock

AFT Pharmaceuticals Equity 2025

AFT Pharmaceuticals Equity

0 NZD

Ticker

AFT.NZ

ISIN

NZAFTE0001S4

WKN

A2DVUC

In 2025, AFT Pharmaceuticals's equity was 0 NZD, a -100% increase from the 73.27 M NZD equity in the previous year.

AFT Pharmaceuticals Aktienanalyse

What does AFT Pharmaceuticals do?

AFT Pharmaceuticals Ltd is a New Zealand pharmaceutical company founded in 1997 by Hartley Atkinson. The company is headquartered in Auckland and operates in multiple countries. Business Model: AFT Pharmaceuticals' business model is focused on developing and marketing high-quality products. The company relies on product innovation and regularly introduces new medicines and supplements to the market. The company offers a wide range of products in various therapeutic areas such as pain management, respiratory diseases, gastrointestinal diseases, and skin conditions. AFT Pharmaceuticals has its own research and development facilities where they continuously work on new formulations and prioritize the needs of patients. The company also relies on partnerships to expand its presence globally and distribute its products in new markets. History: AFT Pharmaceuticals was founded in 1997 by Hartley Atkinson, who started by developing painkillers that were more effective and better tolerated than existing products. The company grew rapidly and expanded its offerings to meet additional medical needs. AFT Pharmaceuticals has since become one of the largest pharmaceutical companies in New Zealand and is expanding internationally. Divisions: An important area of AFT Pharmaceuticals is pain management. The company offers painkillers that are effective and safe, available in various forms. The portfolio includes both over-the-counter and prescription medicines that can be used to relieve pain, including migraine products. Another important area is respiratory diseases. AFT Pharmaceuticals manufactures medications that can be used for allergic rhinitis, asthma, and COPD. The medications are available in various forms such as tablets, syrup, inhalers, and nasal sprays. The company also offers products for gastrointestinal diseases that can be used for conditions such as heartburn, nausea, and vomiting. Dermatology is another important area. AFT Pharmaceuticals produces a variety of products that can be used to treat skin conditions such as eczema and psoriasis. Products: One of AFT Pharmaceuticals' most well-known product lines is Maxigesic, a painkiller that contains a combination of paracetamol and ibuprofen. The medication is available in many countries and is prescribed by doctors for a variety of pain types. Another popular product is Flutiform, an inhaler used for asthma and COPD. The inhaler is easy to use and highly effective. AFT Pharmaceuticals also offers a wide range of dietary supplements that contribute to overall health. These include products like Iron-C, a dietary supplement that contains iron and vitamin C to ensure good oxygen supply in the body. Overall, AFT Pharmaceuticals is a successful pharmaceutical company that offers a broad portfolio of medicines and dietary supplements available in many countries. The company relies on innovation and partnerships to expand its global presence. AFT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing AFT Pharmaceuticals's Equity

AFT Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding AFT Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating AFT Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

AFT Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in AFT Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about AFT Pharmaceuticals stock

What is the equity of AFT Pharmaceuticals this year?

AFT Pharmaceuticals has equity of 0 NZD this year.

What was the equity of AFT Pharmaceuticals compared to the previous year?

The equity of AFT Pharmaceuticals has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of AFT Pharmaceuticals?

A high equity is advantageous for investors of AFT Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of AFT Pharmaceuticals?

A low equity can be a risk for investors of AFT Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of AFT Pharmaceuticals affect the company?

An increase in equity of AFT Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of AFT Pharmaceuticals affect the company?

A reduction in equity of AFT Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of AFT Pharmaceuticals?

Some factors that can affect the equity of AFT Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of AFT Pharmaceuticals so important for investors?

The equity of AFT Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can AFT Pharmaceuticals take to change the equity?

To change equity, AFT Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does AFT Pharmaceuticals pay?

Over the past 12 months, AFT Pharmaceuticals paid a dividend of 0.02 NZD . This corresponds to a dividend yield of about 0.58 %. For the coming 12 months, AFT Pharmaceuticals is expected to pay a dividend of 0.02 NZD.

What is the dividend yield of AFT Pharmaceuticals?

The current dividend yield of AFT Pharmaceuticals is 0.58 %.

When does AFT Pharmaceuticals pay dividends?

AFT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AFT Pharmaceuticals?

AFT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of AFT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0.02 NZD are expected. This corresponds to a dividend yield of 0.58 %.

In which sector is AFT Pharmaceuticals located?

AFT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von AFT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AFT Pharmaceuticals from 7/4/2024 amounting to 0.016 NZD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did AFT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of AFT Pharmaceuticals in the year 2024?

In the year 2024, AFT Pharmaceuticals distributed 0.011 NZD as dividends.

In which currency does AFT Pharmaceuticals pay out the dividend?

The dividends of AFT Pharmaceuticals are distributed in NZD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AFT Pharmaceuticals

Our stock analysis for AFT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AFT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.